Simplified perfusion fraction from diffusion-weighted imaging in preoperative prediction of IDH1 mutation in WHO grade II–III gliomas: comparison with dynamic contrast-enhanced and intravoxel incoherent motion MRI
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Cancer Genome Atlas Research N, Brat DJ, Verhaak RGW, Aldape KD, Yung WKA, Salama SR, et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. The N Engl J Med 2015; 372: 2481-98. doi: 10.1056/NEJMoa1402121CancerGenome Atlas Research NBratDJVerhaakRGWAldapeKDYungWKASalamaSRComprehensive, integrative genomic analysis of diffuse lower-grade gliomasThe N Engl J Med201537224819810.1056/NEJMoa1402121Open DOISearch in Google Scholar
Chang EF, Clark A, Jensen RL, Bernstein M, Guha A, Carrabba G, et al. Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. J Neurosurg 2009; 111: 20310. doi: 10.3171/2009.2.Jns081101ChangEFClarkAJensenRLBernsteinMGuhaACarrabbaGMultiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring SystemJ Neurosurg20091112031010.3171/2009.2.Jns081101Open DOISearch in Google Scholar
Chang EF, Smith JS, Chang SM, Lamborn KR, Prados MD, Butowski N, et al. Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. J Neurosurg 2008; 109: 817-24. doi: 10.3171/jns/2008/109/11/0817ChangEFSmithJSChangSMLambornKRPradosMDButowskiNPreoperative prognostic classification system for hemispheric low-grade gliomas in adultsJ Neurosurg20081098172410.3171/jns/2008/109/11/0817Open DOISearch in Google Scholar
Karim AB, Maat B, Hatlevoll R, Menten J, Rutten EH, Thomas DG, et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 1996; 36: 549-56. doi: 10.1016/s0360-3016(96)00352-5KarimABMaatBHatlevollRMentenJRuttenEHThomasDGA randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844Int J Radiat Oncol Biol Phys1996365495610.1016/s0360-3016(96)00352-5Open DOISearch in Google Scholar
van den Bent MJ. Practice changing mature results of RTOG study 9802: another positive PCV trial makes adjuvant chemotherapy part of standard of care in low-grade glioma. Neuro Oncol 2014; 16: 1570-4. doi: 10.1093/neuonc/nou297vanden Bent MJPractice changing mature results of RTOG study 9802: another positive PCV trial makes adjuvant chemotherapy part of standard of care in low-grade gliomaNeuro Oncol2014161570410.1093/neuonc/nou297423209125355680Open DOISearch in Google Scholar
Delfanti RL, Piccioni DE, Handwerker J, Bahrami N, Krishnan A, Karunamuni R, et al. Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status. J Neurooncol 2017; 135: 601-9. doi: 10.1007/s11060-017-2613-7DelfantiRLPiccioniDEHandwerkerJBahramiNKrishnanAKarunamuniRImaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX statusJ Neurooncol2017135601910.1007/s11060-017-2613-7570084428871469Open DOISearch in Google Scholar
Beiko J, Suki D, Hess KR, Fox BD, Cheung V, Cabral M, et al. IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection. Neuro Oncol 2014; 16: 81-91. doi: 10.1093/neuonc/not159BeikoJSukiDHessKRFoxBDCheungVCabralMIDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resectionNeuro Oncol201416819110.1093/neuonc/not159387082324305719Open DOISearch in Google Scholar
Villani V, Merola R, Vidiri A, Fabi A, Carosi M, Giannarelli D, et al. Temozolomide low-dose chemotherapy in newly diagnosed low-grade gliomas: activity, safety, and long-term follow-up. Tumori 2017; 103: 255-60. doi: 10.5301/tj.5000565VillaniVMerolaRVidiriAFabiACarosiMGiannarelliDTemozolomide low-dose chemotherapy in newly diagnosed low-grade gliomas: activity, safety, and long-term follow-upTumori20171032556010.5301/tj.500056527716874Open DOISearch in Google Scholar
Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011; 473: 298-307. doi: 10.1038/nature10144CarmelietPJainRKMolecular mechanisms and clinical applications of angiogenesisNature201147329830710.1038/nature10144404944521593862Open DOISearch in Google Scholar
Onishi M, Ichikawa T, Kurozumi K, Date I. Angiogenesis and invasion in glioma. Brain Tumor Pathol 2011; 28: 13-24. doi: 10.1007/s10014-010-0007-zOnishiMIchikawaTKurozumiKDateIAngiogenesis and invasion in gliomaBrain Tumor Pathol201128132410.1007/s10014-010-0007-z21221826Open DOISearch in Google Scholar
Gaddikeri S, Gaddikeri RS, Tailor T, Anzai Y. Dynamic contrast-enhanced MR imaging in head and neck cancer: techniques and clinical applications. AJNR Am J Neuroradiol 2016; 37: 588-95. doi: 10.3174/ajnr.A4458GaddikeriSGaddikeriRSTailorTAnzaiYDynamic contrast-enhanced MR imaging in head and neck cancer: techniques and clinical applicationsAJNR Am J Neuroradiol2016375889510.3174/ajnr.A4458796015126427839Open DOISearch in Google Scholar
Roberts HC, Roberts TP, Brasch RC, Dillon WP. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 2000; 21: 891-9.RobertsHCRobertsTPBraschRCDillonWPQuantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic gradeAJNR Am J Neuroradiol2000218919Search in Google Scholar
Knopp EA, Cha S, Johnson G, Mazumdar A, Golfinos JG, Zagzag D, et al. Glial neoplasms: Dynamic Contrast-enhanced T2*-weighted MR imaging. Neuroradiology 1999; 211: 791-8. doi: 10.1148/radiology.211.3.r99jn46791.KnoppEAChaSJohnsonGMazumdarAGolfinosJGZagzagDGlial neoplasms: Dynamic Contrast-enhanced T2*-weighted MR imagingNeuroradiology1999211791810.1148/radiology.211.3.r99jn4679110352608Open DOISearch in Google Scholar
Hino T, Togao O, Hiwatashi A, Yamashita K, Kikuchi K, Momosaka D, et al. Clinical efficacy of simplified intravoxel incoherent motion imaging using three b-values for differentiating high- and low-grade gliomas. PLoS One 2018; 13: e0209796-e. doi: 10.1371/journal.pone.0209796HinoTTogaoOHiwatashiAYamashitaKKikuchiKMomosakaDClinical efficacy of simplified intravoxel incoherent motion imaging using three b-values for differentiating high- and low-grade gliomasPLoS One201813e0209796-e10.1371/journal.pone.0209796630772030589912Open DOISearch in Google Scholar
Wang X, Chen XZ, Shi L, Dai JP. Glioma grading and IDH1 mutational status: assessment by intravoxel incoherent motion MRI. Clin Radiol 2019; 74: 651. e7-651.e14. doi: 10.1016/j.crad.2019.03.020WangXChenXZShiLDaiJPGlioma grading and IDH1 mutational status: assessment by intravoxel incoherent motion MRIClin Radiol201974651e7-651.e1410.1016/j.crad.2019.03.02031014573Open DOISearch in Google Scholar
Koh DM, Collins DJ, Orton MR. Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. AJR Am J Roentgenol 2011; 196: 1351-61. doi: 10.2214/AJR.10.5515KohDMCollinsDJOrtonMRIntravoxel incoherent motion in body diffusion-weighted MRI: reality and challengesAJR Am J Roentgenol201119613516110.2214/AJR.10.551521606299Open DOISearch in Google Scholar
Awasthi R, Rathore RK, Soni P, Sahoo P, Awasthi A, Husain N, et al. Discriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markers. Neuroradiology 2012; 54: 205-13. doi: 10.1007/s00234-011-0874-yAwasthiRRathoreRKSoniPSahooPAwasthiAHusainNDiscriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markersNeuroradiology2012542051310.1007/s00234-011-0874-y21541688Open DOISearch in Google Scholar
Lu S, Gao Q, Yu J, Li Y, Cao P, Shi H, et al. Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor. Eur J Radiol 2016; 85: 1722-7. doi: 10.1016/j.ejrad.2016.07.005LuSGaoQYuJLiYCaoPShiHUtility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumorEur J Radiol2016851722710.1016/j.ejrad.2016.07.00527666608Open DOISearch in Google Scholar
Togao O, Hiwatashi A, Yamashita K, Kikuchi K, Mizoguchi M, Yoshimoto K, et al. Differentiation of high-grade and low-grade diffuse gliomas by intra-voxel incoherent motion MR imaging. Neuro Oncol 2016; 18: 132-41. doi: 10.1093/neuonc/nov147TogaoOHiwatashiAYamashitaKKikuchiKMizoguchiMYoshimotoKDifferentiation of high-grade and low-grade diffuse gliomas by intra-voxel incoherent motion MR imagingNeuro Oncol2016181324110.1093/neuonc/nov147467741526243792Open DOISearch in Google Scholar
Cao M, Suo S, Han X, Jin K, Sun Y, Wang Y, et al. Application of a simplified method for estimating perfusion derived from diffusion-weighted MR imaging in glioma grading. Front Aging Neurosci 2018; 9: 432. doi: 10.3389/fnagi.2017.00432CaoMSuoSHanXJinKSunYWangYApplication of a simplified method for estimating perfusion derived from diffusion-weighted MR imaging in glioma gradingFront Aging Neurosci2018943210.3389/fnagi.2017.00432576663929358915Open DOISearch in Google Scholar
Conklin J, Heyn C, Roux M, Cerny M, Wintermark M, Federau C. A simplified model for intravoxel incoherent motion perfusion imaging of the brain. AJNR Am J Neuroradiol 2016; 37: 2251-7. doi: 10.3174/ajnr.A4929ConklinJHeynCRouxMCernyMWintermarkMFederauCA simplified model for intravoxel incoherent motion perfusion imaging of the brainAJNR Am J Neuroradiol2016372251710.3174/ajnr.A4929796385527561834Open DOISearch in Google Scholar
Shukla-Dave A, Lee NY, Jansen JFA, Thaler HT, Stambuk HE, Fury MG, et al. Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases. Int J Radiat Oncol Biol Phys 2012; 82: 1837-44. doi: 10.1016/j.ijrobp.2011.03.006Shukla-DaveALeeNYJansenJFAThalerHTStambukHEFuryMGDynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastasesInt J Radiat Oncol Biol Phys20128218374410.1016/j.ijrobp.2011.03.006317703421601373Open DOISearch in Google Scholar
Thoeny HC, de Keyzer F, Vandecaveye V, Chen F, Sun X, Bosmans H, et al. Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging. Radiology 2005; 237: 492-9. doi: 10.1148/radiol.2372041638ThoenyHCde KeyzerFVandecaveyeVChenFSunXBosmansHEffect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imagingRadiology2005237492910.1148/radiol.237204163816192323Open DOISearch in Google Scholar
Teruel JR, Goa PE, Sjøbakk TE, Østlie A, Fjøsne HE, Bathen TF. A simplified approach to measure the effect of the microvasculature in diffusion-weighted MR imaging applied to breast tumors: preliminary results. Radiology 2016; 281: 373-81. doi: 10.1148/radiol.2016151630TeruelJRGoaPESjøbakkTEØstlieAFjøsneHEBathenTFA simplified approach to measure the effect of the microvasculature in diffusion-weighted MR imaging applied to breast tumors: preliminary resultsRadiology20162813738110.1148/radiol.201615163027128662Open DOISearch in Google Scholar
Federau C, Maeder P, O’Brien K, Browaeys P, Meuli R, Hagmann P. Quantitative measurement of brain perfusion with intravoxel incoherent motion MR imaging. Radiology 2012; 265: 874-81. doi: 10.1148/radiol.12120584FederauCMaederPO’BrienKBrowaeysPMeuliRHagmannPQuantitative measurement of brain perfusion with intravoxel incoherent motion MR imagingRadiology20122658748110.1148/radiol.1212058423074258Open DOISearch in Google Scholar
Suo S, Cao M, Zhu W, Li L, Li J, Shen F, et al. Stroke assessment with intravoxel incoherent motion diffusion-weighted MRI. NMR Biomed 2016, 29: 320-8. doi: 10.1002/nbm.3467SuoSCaoMZhuWLiLLiJShenFStroke assessment with intravoxel incoherent motion diffusion-weighted MRINMR Biomed201629320810.1002/nbm.346726748572Open DOISearch in Google Scholar
Zhang Q, Wang Y-X, Ma HT, Yuan J. Cramér-Rao bound for intravoxel incoherent motion diffusion weighted imaging fitting. Conf Proc IEEE Eng Med Biol Soc 2013; 2013: 511-4. doi: 10.1109/EMBC.2013.6609549ZhangQWangY-XMaHTYuanJCramér-Rao bound for intravoxel incoherent motion diffusion weighted imaging fittingConf Proc IEEE Eng Med Biol Soc20132013511410.1109/EMBC.2013.660954924109736Open DOISearch in Google Scholar
While PT, Teruel JR, Vidić I, Bathen TF, Goa PE. Relative enhanced diffusivity: noise sensitivity, protocol optimization, and the relation to intravoxel incoherent motion. MAGMA 2018; 31: 425-38. doi: 10.1007/s10334-017-0660-xWhilePTTeruelJRVidićIBathenTFGoaPERelative enhanced diffusivity: noise sensitivity, protocol optimization, and the relation to intravoxel incoherent motionMAGMA2018314253810.1007/s10334-017-0660-x29110241Open DOISearch in Google Scholar
Wu W-C, Chen Y-F, Tseng H-M, Yang S-C, My P-CJER. Caveat of measuring perfusion indexes using intravoxel incoherent motion magnetic resonance imaging in the human brain. Eur Radiol 2015; 25: 2485-92. doi: 10.1007/s00330-015-3655-xWuW-CChenY-FTsengH-MYangS-CMyP-CJERCaveat of measuring perfusion indexes using intravoxel incoherent motion magnetic resonance imaging in the human brainEur Radiol20152524859210.1007/s00330-015-3655-x449526025693668Open DOISearch in Google Scholar
Chung WJ, Kim HS, Kim N, Choi CG, Kim SJ. Recurrent glioblastoma: optimum area under the curve method derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging. Radiology 2013; 269: 561-8. doi: 10.1148/radiol.13130016ChungWJKimHSKimNChoiCGKimSJRecurrent glioblastoma: optimum area under the curve method derived from dynamic contrast-enhanced T1-weighted perfusion MR imagingRadiology2013269561810.1148/radiol.1313001623878286Open DOISearch in Google Scholar
Han X, Suo S, Sun Y, Zu J, Qu J, Zhou Y, et al. Apparent diffusion coefficient measurement in glioma: Influence of region-of-interest determination methods on apparent diffusion coefficient values, interobserver variability, time efficiency, and diagnostic ability. J Magn Reson Imaging 2017; 45: 722-30. doi: 10.1002/jmri.25405HanXSuoSSunYZuJQuJZhouYApparent diffusion coefficient measurement in glioma: Influence of region-of-interest determination methods on apparent diffusion coefficient values, interobserver variability, time efficiency, and diagnostic abilityJ Magn Reson Imaging2017457223010.1002/jmri.2540527527072Open DOISearch in Google Scholar
Park JE, Kim HS, Park KJ, Kim SJ, Kim JH, Smith SA. Pre-and posttreatment glioma: comparison of amide proton transfer imaging with MR spectroscopy for biomarkers of tumor proliferation. Radiology 2015; 278: 514-23. doi: 10.1148/radiol.2015142979ParkJEKimHSParkKJKimSJKimJHSmithSAPre-and posttreatment glioma: comparison of amide proton transfer imaging with MR spectroscopy for biomarkers of tumor proliferationRadiology20152785142310.1148/radiol.2015142979Open DOISearch in Google Scholar
Bisdas S, Braun C, Skardelly M, Schittenhelm J, Teo TH, Thng CH, et al. Correlative assessment of tumor microcirculation using contrast-enhanced perfusion MRI and intravoxel incoherent motion diffusion-weighted MRI: is there a link between them? NMR Biomed 2014; 27: 1184-91. doi: 10.1002/nbm.3172BisdasSBraunCSkardellyMSchittenhelmJTeoTHThngCHCorrelative assessment of tumor microcirculation using contrast-enhanced perfusion MRI and intravoxel incoherent motion diffusion-weighted MRI: is there a link between them?NMR Biomed20142711849110.1002/nbm.3172Open DOISearch in Google Scholar
DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-45.DeLongERDeLongDMClarke-PearsonDLComparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approachBiometrics1988448374510.2307/2531595Search in Google Scholar
Zou T, Yu H, Jiang C, Wang X, Jiang S, Rui Q, et al. Differentiating the histologic grades of gliomas preoperatively using amide proton transfer-weighted (APTW) and intravoxel incoherent motion MRI. NMR Biomed 2018; 31. doi: 10.1002/nbm.3850ZouTYuHJiangCWangXJiangSRuiQDifferentiating the histologic grades of gliomas preoperatively using amide proton transfer-weighted (APTW) and intravoxel incoherent motion MRINMR Biomed20183110.1002/nbm.3850Open DOISearch in Google Scholar
Sugahara T, Korogi Y, Kochi M, Ikushima I, Shigematu Y, Hirai T, et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999; 9: 53-60. doi: 10.1002/(sici)1522-2586(199901)9:1<53::Aid-jmri7>3.0.Co;2-2SugaharaTKorogiYKochiMIkushimaIShigematuYHiraiTUsefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomasJ Magn Reson Imaging19999536010.1002/(sici)1522-2586(199901)9:1<53::Aid-jmri7>3.0.Co;2-2Open DOISearch in Google Scholar
Matsumoto Y, Kuroda M, Matsuya R, Kato H, Shibuya K, Oita M, et al. In vitro experimental study of the relationship between the apparent diffusion coefficient and changes in cellularity and cell morphology. Oncol Rep 2009; 22: 641-8. doi: 10.3892/or_00000484MatsumotoYKurodaMMatsuyaRKatoHShibuyaKOitaMIn vitro experimental study of the relationship between the apparent diffusion coefficient and changes in cellularity and cell morphologyOncol Rep200922641810.3892/or_00000484Open DOISearch in Google Scholar
Chen L, Liu M, Bao J, Xia Y, Zhang J, Zhang L, et al. The Correlation between apparent diffusion coefficient and tumor cellularity in patients: a meta-analysis. PLoS One 2013; 8: e79008. doi: 10.1371/journal.pone.0079008ChenLLiuMBaoJXiaYZhangJZhangLThe Correlation between apparent diffusion coefficient and tumor cellularity in patients: a meta-analysisPLoS One20138e7900810.1371/journal.pone.0079008Open DOISearch in Google Scholar
Provenzale JM, York G, Moya MG, Parks L, Choma M, Kealey S, et al. Correlation of relative permeability and relative cerebral blood volume in high-grade cerebral neoplasms. AJR Am J Roentgenol 2006; 187: 1036-42. doi: 10.2214/AJR.04.0676ProvenzaleJMYorkGMoyaMGParksLChomaMKealeySCorrelation of relative permeability and relative cerebral blood volume in high-grade cerebral neoplasmsAJR Am J Roentgenol200618710364210.2214/AJR.04.0676Open DOISearch in Google Scholar
Mills SJ, Patankar TA, Haroon HA, Balériaux D, Swindell R, Jackson A. Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma? AJNR Am J Neuroradiol 2006; 27: 853-8.MillsSJPatankarTAHaroonHABalériauxDSwindellRJacksonADo cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma?AJNR Am J Neuroradiol2006278538Search in Google Scholar
Houillier C, Wang X, Kaloshi G, Mokhtari K, Guillevin R, Laffaire J, et al. IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas. Neurology 2010; 75: 1560-6. doi: 10.1212/WNL.0b013e3181f96282HouillierCWangXKaloshiGMokhtariKGuillevinRLaffaireJIDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomasNeurology2010751560610.1212/WNL.0b013e3181f96282Open DOISearch in Google Scholar
Beiko J, Suki D, Hess KR, Fox BD, Cheung V, Cabral M, et al. IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection. Neuro Oncol 2014; 16: 81-91. doi: 10.1212/WNL.0b013e3181f96282BeikoJSukiDHessKRFoxBDCheungVCabralMIDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resectionNeuro Oncol201416819110.1212/WNL.0b013e3181f96282Open DOISearch in Google Scholar
Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, et al. Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med 2015; 372: 2499-508. doi: 10.1056/NEJMoa1407279Eckel-PassowJELachanceDHMolinaroAMWalshKMDeckerPASicotteHGlioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumorsN Engl J Med2015372249950810.1056/NEJMoa1407279448970426061753Open DOISearch in Google Scholar
Cohen AL, Holmen SL, Colman H. IDH1 and IDH2 mutations in gliomas. Curr Neurol Neurosci Rep 2013; 13: 345. doi: 10.1007/s11910-013-0345-4CohenALHolmenSLColmanHIDH1 and IDH2 mutations in gliomasCurr Neurol Neurosci Rep20131334510.1007/s11910-013-0345-4410998523532369Open DOISearch in Google Scholar
Zhao S, Lin Y, Xu W, Jiang W, Zha Z, Wang P, et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 2009; 324: 261-5. doi: 10.1126/science.1170944ZhaoSLinYXuWJiangWZhaZWangPGlioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alphaScience2009324261510.1126/science.1170944325101519359588Open DOISearch in Google Scholar
Kickingereder P, Sahm F, Radbruch A, Wick W, Heiland S, Deimling Av, et al. IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma. Sci Rep 2015; 5: 16238. doi: 10.1038/srep16238KickingerederPSahmFRadbruchAWickWHeilandSDeimlingAvIDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human gliomaSci Rep201551623810.1038/srep16238463367226538165Open DOISearch in Google Scholar
Leu K, Ott GA, Lai A, Nghiemphu PL, Pope WB, Yong WH, et al. Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II–III diffuse gliomas. J Neurooncol 2017; 134: 177-88. doi: 10.1007/s11060-017-2506-9LeuKOttGALaiANghiemphuPLPopeWBYongWHPerfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II–III diffuse gliomasJ Neurooncol20171341778810.1007/s11060-017-2506-9792735728547590Open DOISearch in Google Scholar
Brendle C, Hempel JM, Schittenhelm J, Skardelly M, Tabatabai G, Bender B, et al. Glioma grading and determination of IDH mutation status and ATRX loss by DCE and ASL perfusion. Clin Neuroradiol 2018; 28: 421-8. doi: 10.1007/s00062-017-0590-zBrendleCHempelJMSchittenhelmJSkardellyMTabatabaiGBenderBGlioma grading and determination of IDH mutation status and ATRX loss by DCE and ASL perfusionClin Neuroradiol201828421810.1007/s00062-017-0590-z28488024Open DOISearch in Google Scholar
Cui D, Ren J, Shi J, Feng L, Wang K, Zeng T, et al. R132H mutation in IDH1 gene reduces proliferation, cell survival and invasion of human glioma by downregulating Wnt/β-catenin signaling. Int J Biochem Cell Biol 2016; 73: 72-81. doi: 10.1016/j.biocel.2016.02.007CuiDRenJShiJFengLWangKZengTR132H mutation in IDH1 gene reduces proliferation, cell survival and invasion of human glioma by downregulating Wnt/β-catenin signalingInt J Biochem Cell Biol201673728110.1016/j.biocel.2016.02.00726860959Open DOISearch in Google Scholar
Reis M, Czupalla CJ, Ziegler N, Devraj K, Zinke J, Seidel S, et al. Endothelial Wnt/β-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expression. J Exp Med 2012; 209: 161127. doi: 10.1084/jem.20111580ReisMCzupallaCJZieglerNDevrajKZinkeJSeidelSEndothelial Wnt/β-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expressionJ Exp Med201220916112710.1084/jem.20111580342894422908324Open DOISearch in Google Scholar
Koivunen P, Lee S, Duncan CG, Lopez G, Lu G, Ramkissoon S, et al. Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature 2012; 483: 484-8. doi: 10.1038/nature10898KoivunenPLeeSDuncanCGLopezGLuGRamkissoonSTransformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activationNature2012483484810.1038/nature10898365660522343896Open DOISearch in Google Scholar
Villanueva-Meyer JE, Wood MD, Choi BS, Mabray MC, Butowski NA, Tihan T, et al. MRI Features and IDH mutational status of grade II diffuse gliomas: impact on diagnosis and prognosis. AJR Am J Roentgenol 2018; 210: 621-8. doi: 10.2214/AJR.17.18457Villanueva-MeyerJEWoodMDChoiBSMabrayMCButowskiNATihanTMRI Features and IDH mutational status of grade II diffuse gliomas: impact on diagnosis and prognosisAJR Am J Roentgenol2018210621810.2214/AJR.17.18457582375829261348Open DOISearch in Google Scholar
